Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Mirati Therapeutics Net Income 2006-2021 | MRTX

For a detailed definition, formula and example for Net Income, check out our new background page here.
Mirati Therapeutics annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Mirati Therapeutics net income for the quarter ending March 31, 2021 was $-0.136B, a 56.57% increase year-over-year.
  • Mirati Therapeutics net income for the twelve months ending March 31, 2021 was $-0.407B, a 57.13% increase year-over-year.
  • Mirati Therapeutics annual net income for 2020 was $-0.358B, a 67.84% increase from 2019.
  • Mirati Therapeutics annual net income for 2019 was $-0.213B, a 116.68% increase from 2018.
  • Mirati Therapeutics annual net income for 2018 was $-0.098B, a 39.74% increase from 2017.
  
Mirati Therapeutics Annual Net Income
(Millions of US $)
2020 $-358
2019 $-213
2018 $-98
2017 $-70
2016 $-83
2015 $-65
2014 $-44
2013 $-53
2012 $-20
2011 $-10
2010 $-14
2009 $-21
2008 $-8
2007 $-21
2006 $-7
2005 $-13
Mirati Therapeutics Quarterly Net Income
(Millions of US $)
2021-03-31 $-136
2020-12-31 $-101
2020-09-30 $-87
2020-06-30 $-83
2020-03-31 $-87
2019-12-31 $-72
2019-09-30 $-54
2019-06-30 $-46
2019-03-31 $-41
2018-12-31 $-28
2018-09-30 $-28
2018-06-30 $-28
2018-03-31 $-15
2017-12-31 $-18
2017-09-30 $-16
2017-06-30 $-18
2017-03-31 $-18
2016-12-31 $-20
2016-09-30 $-19
2016-06-30 $-22
2016-03-31 $-22
2015-12-31 $-18
2015-09-30 $-19
2015-06-30 $-15
2015-03-31 $-12
2014-12-31 $-10
2014-09-30 $-9
2014-06-30 $-11
2014-03-31 $-14
2013-12-31 $-11
2013-09-30 $-29
2013-06-30 $-8
2013-03-31 $-4
2012-12-31 $-6
2012-09-30 $-6
2012-06-30 $-5
2012-03-31 $-3
2011-12-31 $-4
2011-09-30 $-3
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-5
2010-06-30 $-3
2010-03-31 $-4
2009-12-31 $-5
2009-09-30 $-5
2009-06-30 $-6
2009-03-31 $-5
2008-12-31 $7
2008-09-30 $-3
2008-06-30 $-7
2008-03-31 $-5
2007-12-31 $-7
2007-09-30 $-5
2007-06-30 $-6
2007-03-31 $-3
2006-12-31 $-2
2006-09-30 $3
2006-06-30 $-4
2006-03-31 $-4
2005-12-31 $-4
2005-09-30 $-3
2005-06-30 $-3
2005-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.570B $0.013B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.538B 10.44
Amgen (AMGN) United States $137.807B 14.87
CSL (CSLLY) Australia $105.834B 0.00
Gilead Sciences (GILD) United States $85.397B 9.09
Moderna (MRNA) United States $80.944B 161.27
Illumina (ILMN) United States $65.964B 95.12
Biogen (BIIB) United States $59.632B 13.65
Regeneron Pharmaceuticals (REGN) United States $56.201B 16.09
BioNTech SE (BNTX) Germany $52.693B 38.21
Vertex Pharmaceuticals (VRTX) United States $48.918B 20.15
Alexion Pharmaceuticals (ALXN) United States $40.203B 15.27
BeiGene (BGNE) Cayman Islands $30.549B 0.00
Genmab (GMAB) Denmark $28.886B 33.86
Seagen (SGEN) United States $27.817B 48.05
Genmab (GNMSF) Denmark $26.877B 6.18
Exact Sciences (EXAS) United States $21.027B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.521B 26.24
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.015B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.571B 0.00
CureVac (CVAC) Germany $18.355B 0.00
Incyte (INCY) United States $18.201B 35.98
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $17.163B 90.25
ARGENX SE-ADR (ARGX) Netherlands $16.007B 0.00
Zai Lab (ZLAB) China $15.764B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.978B 136.60
Novavax (NVAX) United States $13.861B 0.00
Guardant Health (GH) United States $11.901B 0.00
QIAGEN (QGEN) Netherlands $10.873B 19.31
Repligen (RGEN) United States $10.412B 93.88
CRISPR Therapeutics AG (CRSP) Switzerland $9.367B 0.00
Denali Therapeutics (DNLI) United States $8.917B 319.91
Fate Therapeutics (FATE) United States $8.161B 0.00
Acceleron Pharma (XLRN) United States $7.813B 0.00
Ascendis Pharma (ASND) Denmark $7.187B 0.00
Exelixis (EXEL) United States $7.095B 113.20
Ultragenyx Pharmaceutical (RARE) United States $6.751B 0.00
Sarepta Therapeutics (SRPT) United States $6.632B 0.00
AbCellera Biologics (ABCL) $6.375B 0.00
Halozyme Therapeutics (HALO) United States $6.115B 33.56
Biohaven Pharmaceutical Holding (BHVN) United States $6.066B 0.00
Intellia Therapeutics (NTLA) United States $6.042B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.955B 21.58
Vir Biotechnology (VIR) United States $5.688B 0.00
Beam Therapeutics (BEAM) United States $5.536B 0.00
Adaptive Biotechnologies (ADPT) United States $5.385B 0.00
Twist Bioscience (TWST) United States $5.313B 0.00
Reata Pharmaceuticals (RETA) United States $5.173B 0.00
Legend Biotech (LEGN) United States $5.166B 0.00
NeoGenomics (NEO) United States $5.140B 871.80
I-Mab (IMAB) China $5.093B 0.00
Galapagos (GLPG) Belgium $5.083B 0.00
Blueprint Medicines (BPMC) United States $4.916B 14.97
Apellis Pharmaceuticals (APLS) United States $4.882B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.208B 0.00
Certara (CERT) United States $4.085B 0.00
Arena Pharmaceuticals (ARNA) United States $3.982B 0.00
Arvinas (ARVN) United States $3.967B 0.00
Alkermes (ALKS) Ireland $3.952B 0.00
SpringWorks Therapeutics (SWTX) United States $3.909B 0.00
Intra-Cellular Therapies (ITCI) United States $3.517B 0.00
Emergent Biosolutions (EBS) United States $3.299B 6.57
Berkeley Lights (BLI) United States $3.099B 0.00
Insmed (INSM) United States $3.033B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
Amicus Therapeutics (FOLD) United States $2.754B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.748B 0.00
Vericel (VCEL) United States $2.664B 718.38
Sorrento Therapeutics (SRNE) United States $2.575B 0.00
MorphoSys AG (MOR) Germany $2.568B 0.00
Global Blood Therapeutics (GBT) United States $2.463B 0.00
Editas Medicine (EDIT) United States $2.381B 0.00
ALX Oncology Holdings (ALXO) United States $2.326B 0.00
Heska (HSKA) United States $2.313B 1008.41
Myriad Genetics (MYGN) United States $2.308B 0.00
Prothena (PRTA) Ireland $2.296B 0.00
Morphic Holding (MORF) United States $2.294B 0.00
Instil Bio (TIL) United States $2.286B 0.00
Bluebird Bio (BLUE) United States $2.214B 0.00
Kymera Therapeutics (KYMR) United States $2.199B 0.00
Revance Therapeutics (RVNC) United States $2.141B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.080B 0.00
Ligand Pharmaceuticals (LGND) United States $2.062B 34.49
Bionano Genomics (BNGO) United States $2.055B 0.00
Atea Pharmaceuticals (AVIR) United States $1.951B 0.00
Seer (SEER) $1.942B 0.00
Amarin (AMRN) Ireland $1.942B 0.00
Myovant Sciences (MYOV) United Kingdom $1.903B 0.00
Seres Therapeutics (MCRB) United States $1.839B 0.00
Castle Biosciences (CSTL) United States $1.819B 0.00
Inovio Pharmaceuticals (INO) United States $1.807B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.805B 0.00
Alector (ALEC) United States $1.793B 0.00
Genetron Holdings (GTH) China $1.783B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Zymeworks (ZYME) Canada $1.765B 0.00
Arcus Biosciences (RCUS) United States $1.731B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.681B 0.00
Protagonist Therapeutics (PTGX) United States $1.677B 0.00
PureTech Health (PRTC) United States $1.652B 0.00
C4 Therapeutics (CCCC) United States $1.627B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
Cytokinetics (CYTK) United States $1.598B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.589B 0.00
UniQure (QURE) Netherlands $1.586B 0.00
REGENXBIO (RGNX) United States $1.554B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.507B 0.00
NGM Biopharmaceuticals (NGM) United States $1.480B 0.00
Avid Bioservices (CDMO) United States $1.448B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.446B 0.00
Precigen (PGEN) United States $1.391B 0.00
Zealand Pharma (ZEAL) Denmark $1.364B 0.00
Codexis (CDXS) United States $1.345B 0.00
Nurix Therapeutics (NRIX) United States $1.344B 0.00
BioAtla (BCAB) United States $1.334B 0.00
Northwest Biotherapeutics (NWBO) United States $1.323B 0.00
MiMedx (MDXG) United States $1.244B 0.00
Ocugen (OCGN) United States $1.241B 0.00
Keros Therapeutics (KROS) United States $1.219B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.185B 0.00
Repare Therapeutics (RPTX) Canada $1.171B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Celldex Therapeutics (CLDX) United States $1.157B 0.00
Shattuck Labs (STTK) United States $1.154B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Pliant Therapeutics (PLRX) United States $1.125B 0.00
Agenus (AGEN) United States $1.121B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.077B 34.00
Coherus BioSciences (CHRS) United States $1.069B 0.00
Mesoblast (MESO) Australia $1.068B 0.00
Prometheus Biosciences (RXDX) United States $1.049B 0.00
Scholar Rock Holding (SRRK) United States $1.044B 0.00
MannKind (MNKD) United States $1.022B 0.00
Dynavax Technologies (DVAX) United States $1.019B 0.00
Mersana Therapeutics (MRSN) United States $1.016B 0.00
VBI Vaccines (VBIV) United States $0.996B 0.00
Avidity Biosciences (RNA) United States $0.990B 0.00
Inhibrx (INBX) United States $0.981B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.924B 0.00
G1 THERAPEUTICS (GTHX) United States $0.919B 0.00
Travere Therapeutics (TVTX) United States $0.903B 0.00
Epizyme (EPZM) United States $0.895B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.882B 0.00
RAPT THERAPTICS (RAPT) United States $0.880B 0.00
Cel-Sci (CVM) United States $0.860B 0.00
Sutro Biopharma (STRO) United States $0.843B 0.00
Nkarta (NKTX) United States $0.825B 0.00
Merus (MRUS) Netherlands $0.821B 0.00
Verastem (VSTM) United States $0.803B 0.00
Affimed (AFMD) Germany $0.801B 0.00
Pharming Group (PHAR) Netherlands $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
Xenon Pharmaceuticals (XENE) Canada $0.737B 0.00
SESEN BIO, INC (SESN) United States $0.728B 0.00
IDEAYA Biosciences (IDYA) United States $0.726B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.724B 0.00
Cara Therapeutics (CARA) United States $0.710B 61.65
Curis (CRIS) United States $0.697B 0.00
DBV Technologies S.A (DBVT) France $0.694B 0.00
Kadmon Holdings (KDMN) United States $0.688B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.685B 0.00
Cellectis S.A (CLLS) France $0.685B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.684B 0.00
MeiraGTx Holdings (MGTX) United States $0.679B 0.00
ChromaDex (CDXC) United States $0.675B 0.00
AnaptysBio (ANAB) United States $0.670B 0.00
Clene (CLNN) United States $0.668B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Brooklyn ImmunoTherapeutics (BTX) United States $0.636B 0.00
Precision BioSciences (DTIL) United States $0.631B 0.00
ALBIREO PHARMA (ALBO) United States $0.631B 0.00
Anika Therapeutics (ANIK) United States $0.615B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.606B 0.00
Clovis Oncology (CLVS) United States $0.603B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.600B 0.00
Adagene (ADAG) China $0.592B 0.00
Bolt Biotherapeutics (BOLT) United States $0.592B 0.00
Inventiva S.A (IVA) France $0.587B 0.00
Selecta Biosciences (SELB) United States $0.565B 0.00
Compugen (CGEN) Israel $0.558B 0.00
Forte Biosciences (FBRX) United States $0.538B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.538B 0.00
Codiak BioSciences (CDAK) United States $0.530B 0.00
AC Immune SA (ACIU) Switzerland $0.526B 0.00
Starpharma Holdings (SPHRY) Australia $0.522B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.480B 0.00
Gritstone Bio (GRTS) United States $0.479B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.469B 0.00
BeyondSpring (BYSI) United States $0.461B 0.00
CytomX Therapeutics (CTMX) United States $0.460B 0.00
Spero Therapeutics (SPRO) United States $0.452B 0.00
Athenex (ATNX) United States $0.449B 0.00
Oncobiologics (OTLK) United States $0.448B 0.00
Geron (GERN) United States $0.443B 0.00
Neoleukin Therapeutics (NLTX) United States $0.434B 0.00
Puma Biotechnology (PBYI) United States $0.427B 0.00
ANI Pharmaceuticals (ANIP) United States $0.423B 11.69
Amryt Pharma (AMYT) United Kingdom $0.417B 0.00
Cue Biopharma (CUE) United States $0.414B 0.00
AquaBounty Technologies (AQB) United States $0.411B 0.00
Angion Biomedica (ANGN) United States $0.393B 0.00
SQZ Biotechnologies (SQZ) United States $0.378B 0.00
Opthea (OPT) Australia $0.374B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.373B 0.00
Kala Pharmaceuticals (KALA) United States $0.368B 0.00
Adverum Biotechnologies (ADVM) United States $0.358B 0.00
UROGEN PHARMA (URGN) United States $0.357B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Syros Pharmaceuticals (SYRS) United States $0.355B 0.00
Fortress Biotech (FBIO) United States $0.353B 0.00
BioDelivery Sciences (BDSI) United States $0.352B 14.28
Adicet Bio (ACET) United States $0.349B 0.00
Cogent Biosciences (COGT) United States $0.348B 0.00
XOMA (XOMA) United States $0.346B 161.63
IBio (IBIO) United States $0.342B 0.00
Athersys (ATHX) United States $0.342B 0.00
Theratechnologies (THTX) Canada $0.341B 0.00
Cerecor (CERC) United States $0.340B 0.00
Prima BioMed (IMMP) Australia $0.332B 0.00
Frequency Therapeutics (FREQ) United States $0.331B 0.00
Trevena (TRVN) United States $0.330B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.322B 0.00
Innate Pharma S.A (IPHA) France $0.317B 0.00
Arbutus Biopharma (ABUS) United States $0.307B 0.00
CorMedix Inc (CRMD) United States $0.304B 0.00
Cardiff Oncology (CRDF) United States $0.300B 0.00
OVID THERAPEUTC (OVID) United States $0.299B 2.94
Kindred Biosciences (KIN) United States $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Talis Biomedical (TLIS) United States $0.281B 0.00
Kaleido Biosciences (KLDO) $0.279B 0.00
Fulcrum Therapeutics (FULC) United States $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.273B 0.00
Bellus Health (BLU) Canada $0.270B 0.00
INmune Bio (INMB) United States $0.269B 0.00
Kamada (KMDA) Israel $0.259B 17.61
HOOKIPA Pharma (HOOK) United States $0.250B 0.00
Seelos Therapeutics (SEEL) United States $0.244B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.241B 0.00
Clearside Biomedical (CLSD) United States $0.240B 0.00
Aptinyx (APTX) United States $0.238B 0.00
Chiasma (CHMA) United States $0.236B 0.00
ADMA Biologics Inc (ADMA) United States $0.228B 0.00
NextCure (NXTC) United States $0.225B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.221B 0.00
VTv Therapeutics (VTVT) United States $0.208B 0.00
Synlogic (SYBX) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.196B 0.00
Applied Genetic Technologies (AGTC) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.190B 0.00
TELA Bio (TELA) United States $0.189B 0.00
OSMOTICA PHARM (OSMT) United States $0.188B 0.00
GENFIT S.A (GNFT) France $0.188B 0.00
VolitionRX (VNRX) United States $0.184B 0.00
Voyager Therapeutics (VYGR) United States $0.177B 4.56
ObsEva SA (OBSV) Switzerland $0.174B 0.00
Galena Biopharma (SLS) United States $0.173B 0.00
Nicox SA (NICXF) France $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Eton Pharmaceuticals (ETON) United States $0.167B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
DiaMedica Therapeutics (DMAC) United States $0.162B 0.00
Antibe Therapeutics (ATBPF) Canada $0.159B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.157B 0.00
Yumanity Therapeutics (YMTX) United States $0.153B 0.00
Exicure (XCUR) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.145B 42.86
LogicBio Therapeutics (LOGC) United States $0.142B 0.00
Novogen (KZIA) Australia $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Eyenovia (EYEN) United States $0.138B 0.00
Erytech Pharma SA (ERYP) France $0.138B 0.00
Liminal BioSciences (LMNL) Canada $0.136B 0.00
Catalyst Biosciences (CBIO) United States $0.134B 0.00
Aptevo Therapeutics (APVO) United States $0.133B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Pluristem Therapeutics (PSTI) Israel $0.132B 0.00
Aytu BioPharma (AYTU) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.129B 0.00
Palatin Technologies (PTN) United States $0.128B 0.00
Longeveron (LGVN) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 259.50
ABVC BioPharma (ABVC) United States $0.127B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.124B 0.00
Beyond Air (XAIR) United States $0.118B 0.00
Vyant Bio (VYNT) United States $0.115B 0.00
Vascular Biogenics (VBLT) Israel $0.114B 0.00
Celsion (CLSN) United States $0.113B 0.00
Zosano Pharma (ZSAN) United States $0.109B 0.00
ARAVIVE, INC (ARAV) United States $0.109B 0.00
Leap Therapeutics (LPTX) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.105B 0.00
CytRx (CYTR) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
TRACON Pharmaceuticals (TCON) United States $0.098B 0.00
Dyadic (DYAI) United States $0.097B 0.00
Protalix BioTherapeutics (PLX) Israel $0.097B 0.00
AIkido Pharma (AIKI) United States $0.094B 0.00
Evogene (EVGN) Israel $0.093B 0.00
Lumos Pharma (LUMO) United States $0.092B 0.00
Purple Biotech (PPBT) Israel $0.092B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.088B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.087B 0.00
ARIDIS PHARMACT (ARDS) United States $0.081B 0.00
Cleveland BioLabs (CBLI) United States $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Celyad SA (CYAD) Belgium $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.076B 0.00
BioCardia (BCDA) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Advaxis (ADXS) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Viridian Therapeutics (VRDN) United States $0.070B 0.00
Cyclo Therapeutics (CYTH) United States $0.065B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Genetic Technologies (GENE) Australia $0.061B 0.00
AEterna Zentaris (AEZS) United States $0.060B 0.00
Windtree Therapeutics (WINT) United States $0.060B 0.00
Organovo Holdings (ONVO) United States $0.059B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Invo BioScience (INVO) United States $0.047B 0.00
Soligenix (SNGX) United States $0.047B 0.00
Enveric Biosciences (ENVB) United States $0.047B 0.00
Timber Pharmaceuticals (TMBR) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.042B 0.00
Acorda Therapeutics (ACOR) United States $0.040B 0.96
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
Benitec Biopharma (BNTC) United States $0.035B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.034B 0.00
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00